Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Grandér

Showing results (1-10 of 55) with videos related to

Pageof 6
Sort By:
Acta Oncologica (Stockholm, Sweden)|January 6, 2001
How does interferon-alpha exert its antitumour activity in multiple myeloma?D Grandér
Medical Oncology (Northwood, London, England)|June 27, 1998
How do mutated oncogenes and tumor suppressor genes cause cancer?D Grandér
Acta Oncologica (Stockholm, Sweden)|September 22, 1998
Interferon and malignant disease--how does it work and why doesn't it always?D Grandér, S Einhorn
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Cytotoxic effect of interferon on primary malignant tumour cells. Studies in various malignanciesD Grandér, B Xu, S Einhorn
European Journal of Haematology|October 6, 1997
How does interferon exert its cell growth inhibitory effect?D Grandér, O Sangfelt, S Erickson
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Measurement of interferon sensitivity in tumour cells from fine-needle aspirationsD Grandér, L Skoog, E Tani, et al.
Oncogene|January 30, 1997
Induction of Cip/Kip and Ink4 cyclin dependent kinase inhibitors by interferon-alpha in hematopoietic cell linesO Sangfelt, S Erickson, S Einhorn, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|October 22, 1998
In vivo induction of the interferon-stimulated protein 2'5'-oligoadenylate synthetase in tumor and peripheral blood cells during IFN-alpha treatment of metastatic melanomaD Grandér, O Sangfelt, L Skoog, et al.
Leukemia|February 1, 1994
Gamma-IFN induced cell adhesion in chronic myelogenous leukemia cellsD Grandér, B Xu, P Wang, et al.
Blood|September 15, 1994
Primary leukemia cells resistant to alpha-interferon in vitro are defective in the activation of the DNA-binding factor interferon-stimulated gene factor 3B Xu, D Grandér, O Sangfelt, et al.
Pageof 6

Showing results (1-10 of 55) with videos related to

Sort By:
Pageof 6
Acta Oncologica (Stockholm, Sweden)|January 6, 2001
How does interferon-alpha exert its antitumour activity in multiple myeloma?D Grandér
Medical Oncology (Northwood, London, England)|June 27, 1998
How do mutated oncogenes and tumor suppressor genes cause cancer?D Grandér
Acta Oncologica (Stockholm, Sweden)|September 22, 1998
Interferon and malignant disease--how does it work and why doesn't it always?D Grandér, S Einhorn
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Cytotoxic effect of interferon on primary malignant tumour cells. Studies in various malignanciesD Grandér, B Xu, S Einhorn
European Journal of Haematology|October 6, 1997
How does interferon exert its cell growth inhibitory effect?D Grandér, O Sangfelt, S Erickson
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Measurement of interferon sensitivity in tumour cells from fine-needle aspirationsD Grandér, L Skoog, E Tani, et al.
Oncogene|January 30, 1997
Induction of Cip/Kip and Ink4 cyclin dependent kinase inhibitors by interferon-alpha in hematopoietic cell linesO Sangfelt, S Erickson, S Einhorn, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|October 22, 1998
In vivo induction of the interferon-stimulated protein 2'5'-oligoadenylate synthetase in tumor and peripheral blood cells during IFN-alpha treatment of metastatic melanomaD Grandér, O Sangfelt, L Skoog, et al.
Leukemia|February 1, 1994
Gamma-IFN induced cell adhesion in chronic myelogenous leukemia cellsD Grandér, B Xu, P Wang, et al.
Blood|September 15, 1994
Primary leukemia cells resistant to alpha-interferon in vitro are defective in the activation of the DNA-binding factor interferon-stimulated gene factor 3B Xu, D Grandér, O Sangfelt, et al.
Pageof 6